SCHEMBL23680978

SCHEMBL23680978

COCCNS(=O)(=O)c1cc(C(=O)O)cc(-c2ccc(CN)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
LMNA P02545 3/20 0.53
HPGD P15428 2/20 0.53
MAPT P10636 2/20 0.53
KDM4E B2RXH2 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
HTT P42858 3/20 0.49
AKR1C3 P42330 6/20 0.47
KMT2A Q03164 2/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PKM P14618 2/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
CYP2C19 P33261 1/20 0.43
KCNH2 Q12809 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23680976 0.86 ALDH1A1 (0.56) ALDH1A1LMNAHPGDMAPTKDM4E
SCHEMBL19580347 0.78 ALDH1A1 (0.71) ALDH1A1LMNAHPGDMAPTKDM4E
SCHEMBL2281070 0.77 CYP2C19 (0.70) ALDH1A1MAPTHTTAKR1C3KMT2A
SCHEMBL23680979 0.76 MAPT (0.47) ALDH1A1LMNAHPGDMAPTKDM4E
SCHEMBL13543488 0.74 ALDH1A1 (0.69) ALDH1A1LMNAHPGDMAPTKDM4E
SCHEMBL28954097 0.68 DHODH (0.47) HRH3LOXL2
SCHEMBL13545200 0.68 ALDH1A1 (0.52) ALDH1A1LMNAHPGDMAPTKDM4E
SCHEMBL27893517 0.68 ALDH1A1 (0.67) ALDH1A1LMNAHPGDMAPTKDM4E
SCHEMBL28210660 0.67 DHODH (0.46) HRH3LOXL2
SCHEMBL13543278 0.67 ALDH1A1 (0.51) ALDH1A1LMNAHPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021150871-A1 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS WITH RIPK1/RIPK3 INHIBITORS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-07-29 WO disclosed